Corcept Therapeutics Incorporated (CORT)
USD 73.58
(-7.29%)
USD 73.58
(-7.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -135.4 Million USD | 68.91% |
| 2022 | -435.47 Million USD | -29.88% |
| 2021 | -335.28 Million USD | 29.32% |
| 2020 | -474.34 Million USD | -52.1% |
| 2019 | -311.85 Million USD | -50.83% |
| 2018 | -206.76 Million USD | -98.76% |
| 2017 | -104.02 Million USD | -182.12% |
| 2016 | -36.87 Million USD | -44.77% |
| 2015 | -25.47 Million USD | -71.82% |
| 2014 | -14.82 Million USD | 69.83% |
| 2013 | -49.13 Million USD | 45.64% |
| 2012 | -90.38 Million USD | -128.04% |
| 2011 | -39.63 Million USD | -61.26% |
| 2010 | -24.57 Million USD | -3.0% |
| 2009 | -23.86 Million USD | -62.32% |
| 2008 | -14.7 Million USD | -28.9% |
| 2007 | -11.4 Million USD | -28.66% |
| 2006 | -8.86 Million USD | -135.62% |
| 2005 | -3.76 Million USD | 36.56% |
| 2004 | -5.93 Million USD | 37.9% |
| 2003 | -9.54 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -122.91 Million USD | 17.88% |
| 2024 Q1 | -149.67 Million USD | -10.54% |
| 2024 Q3 | -130.49 Million USD | -6.17% |
| 2023 Q4 | -135.4 Million USD | -21.35% |
| 2023 Q2 | -172.08 Million USD | 62.95% |
| 2023 FY | -135.4 Million USD | 68.91% |
| 2023 Q3 | -111.57 Million USD | 35.16% |
| 2023 Q1 | -464.48 Million USD | -6.66% |
| 2022 Q3 | -48.53 Million USD | 87.22% |
| 2022 Q2 | -379.71 Million USD | -543.08% |
| 2022 Q4 | -435.47 Million USD | -797.22% |
| 2022 Q1 | -59.04 Million USD | 82.39% |
| 2022 FY | -435.47 Million USD | -29.88% |
| 2021 Q3 | -93.64 Million USD | 0.24% |
| 2021 FY | -335.28 Million USD | 29.32% |
| 2021 Q2 | -93.87 Million USD | -86.57% |
| 2021 Q4 | -335.28 Million USD | -258.05% |
| 2021 Q1 | -50.31 Million USD | 89.39% |
| 2020 FY | -474.34 Million USD | -52.1% |
| 2020 Q4 | -474.34 Million USD | -1623.06% |
| 2020 Q1 | -345.89 Million USD | -10.92% |
| 2020 Q3 | -27.52 Million USD | 49.96% |
| 2020 Q2 | -55.01 Million USD | 84.09% |
| 2019 Q2 | -224.55 Million USD | -366.57% |
| 2019 Q3 | -44.17 Million USD | 80.33% |
| 2019 FY | -311.85 Million USD | -50.83% |
| 2019 Q4 | -311.85 Million USD | -605.9% |
| 2019 Q1 | -48.12 Million USD | 76.72% |
| 2018 FY | -206.76 Million USD | -98.76% |
| 2018 Q1 | -140.37 Million USD | -34.94% |
| 2018 Q3 | -33.89 Million USD | -8.76% |
| 2018 Q2 | -31.16 Million USD | 77.8% |
| 2018 Q4 | -206.76 Million USD | -510.02% |
| 2017 Q2 | -63.08 Million USD | -33.77% |
| 2017 Q1 | -47.16 Million USD | -27.9% |
| 2017 FY | -104.02 Million USD | -182.12% |
| 2017 Q4 | -104.02 Million USD | -35.69% |
| 2017 Q3 | -76.66 Million USD | -21.52% |
| 2016 Q3 | -29.14 Million USD | -49.53% |
| 2016 Q4 | -36.87 Million USD | -26.53% |
| 2016 Q2 | -19.48 Million USD | 20.2% |
| 2016 Q1 | -24.42 Million USD | 4.11% |
| 2016 FY | -36.87 Million USD | -44.77% |
| 2015 FY | -25.47 Million USD | -71.82% |
| 2015 Q1 | -27.29 Million USD | -84.13% |
| 2015 Q2 | -25.01 Million USD | 8.36% |
| 2015 Q3 | -22.94 Million USD | 8.28% |
| 2015 Q4 | -25.47 Million USD | -11.01% |
| 2014 Q4 | -14.82 Million USD | 18.19% |
| 2014 Q3 | -18.11 Million USD | 31.83% |
| 2014 Q2 | -26.57 Million USD | 27.62% |
| 2014 Q1 | -36.72 Million USD | 25.26% |
| 2014 FY | -14.82 Million USD | 69.83% |
| 2013 Q1 | -77.56 Million USD | 14.19% |
| 2013 FY | -49.13 Million USD | 45.64% |
| 2013 Q4 | -49.13 Million USD | 16.26% |
| 2013 Q3 | -58.67 Million USD | 14.43% |
| 2013 Q2 | -68.57 Million USD | 11.59% |
| 2012 Q3 | -71.05 Million USD | -103.6% |
| 2012 Q2 | -34.89 Million USD | 18.13% |
| 2012 FY | -90.38 Million USD | -128.04% |
| 2012 Q1 | -42.62 Million USD | -7.55% |
| 2012 Q4 | -90.38 Million USD | -27.2% |
| 2011 Q2 | -52.23 Million USD | 11.78% |
| 2011 Q1 | -59.2 Million USD | -140.87% |
| 2011 Q4 | -39.63 Million USD | 13.67% |
| 2011 Q3 | -45.9 Million USD | 12.1% |
| 2011 FY | -39.63 Million USD | -61.26% |
| 2010 Q3 | -29 Million USD | 18.04% |
| 2010 Q2 | -35.38 Million USD | -90.82% |
| 2010 Q4 | -24.57 Million USD | 15.25% |
| 2010 Q1 | -18.54 Million USD | 22.28% |
| 2010 FY | -24.57 Million USD | -3.0% |
| 2009 Q4 | -23.86 Million USD | -122.85% |
| 2009 Q1 | -19.18 Million USD | -30.48% |
| 2009 Q3 | -10.7 Million USD | 25.83% |
| 2009 Q2 | -14.43 Million USD | 24.74% |
| 2009 FY | -23.86 Million USD | -62.32% |
| 2008 FY | -14.7 Million USD | -28.9% |
| 2008 Q4 | -14.7 Million USD | 9.82% |
| 2008 Q3 | -16.3 Million USD | 37.54% |
| 2008 Q2 | -26.1 Million USD | 17.83% |
| 2008 Q1 | -31.76 Million USD | -178.54% |
| 2007 Q4 | -11.4 Million USD | 38.46% |
| 2007 Q3 | -18.53 Million USD | -55.55% |
| 2007 Q1 | -14.7 Million USD | -65.9% |
| 2007 Q2 | -11.91 Million USD | 18.98% |
| 2007 FY | -11.4 Million USD | -28.66% |
| 2006 Q2 | -3.77 Million USD | -81.21% |
| 2006 Q4 | -8.86 Million USD | -172.65% |
| 2006 FY | -8.86 Million USD | -135.62% |
| 2006 Q3 | -3.25 Million USD | 13.79% |
| 2006 Q1 | -2.08 Million USD | 44.68% |
| 2005 Q2 | -2.81 Million USD | 19.57% |
| 2005 Q1 | -3.5 Million USD | 40.96% |
| 2005 FY | -3.76 Million USD | 36.56% |
| 2005 Q4 | -3.76 Million USD | -175.2% |
| 2005 Q3 | -1.36 Million USD | 51.46% |
| 2004 Q2 | -35.23 Million USD | -316.27% |
| 2004 Q1 | -8.46 Million USD | 11.36% |
| 2004 Q4 | -5.93 Million USD | 73.07% |
| 2004 FY | -5.93 Million USD | 37.9% |
| 2004 Q3 | -22.02 Million USD | 37.5% |
| 2003 FY | -9.54 Million USD | 0.0% |
| 2003 Q4 | -9.54 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -142.045% |
| Alkermes plc | -166.73 Million USD | 18.795% |
| Agenus Inc. | 274.13 Million USD | 149.392% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.241% |
| Aptorum Group Limited | 1.35 Million USD | 10077.554% |
| Ardelyx, Inc. | 34.51 Million USD | 492.327% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3263.551% |
| Bicycle Therapeutics plc | -481.46 Million USD | 71.878% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 474.416% |
| ChromaDex Corporation | -24.04 Million USD | -463.041% |
| Chimerix, Inc. | -25.51 Million USD | -430.627% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2043.148% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -471.863% |
| CRISPR Therapeutics AG | -150.84 Million USD | 10.239% |
| Precision BioSciences, Inc. | -85.41 Million USD | -58.529% |
| Dyadic International, Inc. | -6.37 Million USD | -2022.89% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -749.809% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1866.471% |
| Lantern Pharma Inc. | -21.7 Million USD | -523.869% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -22.493% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1484.891% |
| Incyte Corporation | -3.17 Billion USD | 95.736% |
| IO Biotech, Inc. | -140.69 Million USD | 3.766% |
| Jaguar Health, Inc. | 29.39 Million USD | 560.685% |
| Novavax, Inc. | -298.29 Million USD | 54.609% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2637.006% |
| Opthea Limited | 28.15 Million USD | 580.867% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -706.48% |
| ContextLogic Inc. | -232 Million USD | 41.638% |
| MiMedx Group, Inc. | -33.9 Million USD | -299.398% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1428.102% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5743.695% |
| NextCure, Inc. | -6.47 Million USD | -1990.474% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -168.114% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2022.59% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1213.188% |
| Vaxcyte, Inc. | -368.22 Million USD | 63.229% |
| PDS Biotechnology Corporation | -32.7 Million USD | -313.955% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 883.656% |
| Pharming Group N.V. | 109.8 Million USD | 223.311% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -678.34% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 22.73% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -631.107% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -631.107% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1807.042% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2210.58% |
| Acelyrin, Inc. | -216.9 Million USD | 37.576% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2313.432% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7753.828% |
| Summit Therapeutics Inc. | 34.67 Million USD | 490.494% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1890.298% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7881.609% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 26.655% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -74.82% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2133.586% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 135813.498% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 21660.51% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -15.681% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 19.516% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 222.125% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1682.517% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -4.869% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2063.856% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 44.133% |
| Immix Biopharma, Inc. | -17.5 Million USD | -673.282% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 57.247% |
| MEI Pharma, Inc. | -3.7 Million USD | -3554.521% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1182.248% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 183.714% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 587.173% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1866.471% |
| Precigen, Inc. | -481 Thousand USD | -28049.688% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1061.579% |
| AlloVir, Inc. | -62.69 Million USD | -115.977% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -143.464% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 319.57% |
| ImmuCell Corporation | 10.99 Million USD | 1331.966% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 12.161% |
| Onconetix, Inc. | 5.33 Million USD | 2639.653% |
| PureTech Health plc | -167.19 Million USD | 19.018% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -344.517% |
| Elevation Oncology, Inc. | -19.11 Million USD | -608.233% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2658.199% |
| Seer, Inc. | -4.24 Million USD | -3093.396% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -463.298% |
| Innoviva, Inc. | 255.56 Million USD | 152.981% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -142.374% |
| ESSA Pharma Inc. | -33.62 Million USD | -302.717% |
| GlycoMimetics, Inc. | -40.98 Million USD | -230.369% |
| GT Biopharma, Inc. | -1.02 Million USD | -13161.508% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -99.755% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 321.036% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -0.985% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -877.194% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -368.966% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -179632.923% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -338.727% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1552.256% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4227.236% |
| Soligenix, Inc. | -4.95 Million USD | -2634.471% |
| Century Therapeutics, Inc. | 847 Thousand USD | 16085.832% |
| Kura Oncology, Inc. | -20.11 Million USD | -573.029% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -230.841% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1512.289% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7532.638% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4135.221% |
| Autolus Therapeutics plc | -186.59 Million USD | 27.438% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -174.623% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 50.905% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 495.121% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 182.376% |
| GRI Bio, Inc. | -1.79 Million USD | -7447.38% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1407.284% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -307.132% |
| IGM Biosciences, Inc. | -72.6 Million USD | -86.486% |
| INmune Bio, Inc. | -25.41 Million USD | -432.84% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 189.698% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -167.277% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -733.263% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4593.361% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 456.175% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -228.76% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 524.651% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 135.825% |
| Verastem, Inc. | -37.27 Million USD | -263.217% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1392.34% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -161.077% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -794.615% |
| Histogen Inc. | -7.48 Million USD | -1708.468% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -526.654% |
| Surrozen, Inc. | -32.66 Million USD | -314.524% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8884.738% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3121.134% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 814.127% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5275.841% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3357.94% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1515.53% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -211.68% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -828.869% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 57.259% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -18651.904% |
| Apollomics, Inc. | -27.39 Million USD | -394.251% |
| Amarin Corporation plc | -191.04 Million USD | 29.125% |
| Mesoblast Limited | 55.96 Million USD | 341.946% |
| Turnstone Biologics Corp. | -14.58 Million USD | -828.415% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -435.347% |
| Synaptogenix, Inc. | -28.66 Million USD | -372.411% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -14365.812% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 377.846% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15606.035% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1763.453% |
| Exelixis, Inc. | -73.05 Million USD | -85.352% |
| Better Therapeutics, Inc. | -860 Thousand USD | -15644.186% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -463.861% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 43.904% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18495.09% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1720.349% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10897.448% |
| Gritstone bio, Inc. | 39.49 Million USD | 442.872% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -60.997% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -5044.103% |
| Avid Bioservices, Inc. | 169.72 Million USD | 179.775% |
| Insmed Incorporated | 721.62 Million USD | 118.763% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1381.155% |
| MediWound Ltd. | -5.32 Million USD | -2444.156% |
| OmniAb, Inc. | 9.2 Million USD | 1571.259% |
| Alector, Inc. | -35.63 Million USD | -279.942% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 257.495% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2647.565% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1122.736% |
| Zai Lab Limited | -775 Million USD | 82.529% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 139.759% |
| Aura Biosciences, Inc. | -21.52 Million USD | -529.036% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -64.161% |
| Immunic, Inc. | -45.34 Million USD | -198.633% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 29.923% |
| Veracyte, Inc. | -203.82 Million USD | 33.57% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 121.213% |
| FibroGen, Inc. | 56.76 Million USD | 338.519% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1620.494% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4689.391% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6439.963% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.95% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3952.679% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 18.416% |
| TG Therapeutics, Inc. | 17.86 Million USD | 858.034% |
| Galecto, Inc. | -21.21 Million USD | -538.198% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -469.266% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.628% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -453.285% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1076.675% |
| XBiotech Inc. | -200.02 Million USD | 32.308% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -60.997% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3090.283% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -283.972% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -75.348% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2479.195% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 20.547% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -46.578% |
| Vaxxinity, Inc. | 10.13 Million USD | 1436.36% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 118.39% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1157.482% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -105.288% |
| NexImmune, Inc. | -3.13 Million USD | -4220.85% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3821.599% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -796.009% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -399.631% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1408.458% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -108589.544% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -233.728% |
| Ainos, Inc. | 4.07 Million USD | 3420.314% |
| Pluri Inc. | 22.82 Million USD | 693.105% |
| Prothena Corporation plc | -608.34 Million USD | 77.743% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -14.015% |
| Celularity Inc. | 65.19 Million USD | 307.701% |
| Rallybio Corporation | -24.1 Million USD | -461.779% |
| Cue Biopharma, Inc. | -33.81 Million USD | -300.367% |
| MeiraGTx Holdings plc | -40.3 Million USD | -235.963% |
| Omeros Corporation | 331.17 Million USD | 140.885% |
| Humacyte, Inc. | -22.48 Million USD | -502.152% |
| Immunocore Holdings plc | -358.59 Million USD | 62.241% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -450.966% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -338.174% |
| Blueprint Medicines Corporation | 702.83 Million USD | 119.265% |
| CalciMedica, Inc. | -5.53 Million USD | -2348.463% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 28.063% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1225.631% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -238.187% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -307.181% |
| Pulmatrix, Inc. | -10.41 Million USD | -1199.798% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2165.351% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -254.989% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -21.542% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -125.877% |
| Cytokinetics, Incorporated | 642.37 Million USD | 121.078% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2225.262% |
| Nutriband Inc. | -251.65 Thousand USD | -53703.391% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -296.846% |
| Vor Biopharma Inc. | 4.3 Million USD | 3248.837% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.757% |
| Evogene Ltd. | -19.63 Million USD | -589.62% |
| ProKidney Corp. | -56.23 Million USD | -140.771% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -178.189% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1365.814% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.927% |
| CorMedix Inc. | -43.05 Million USD | -214.5% |
| BioLineRx Ltd. | 7.33 Million USD | 1945.692% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -392.991% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 393.41% |
| Atai Life Sciences N.V. | -28.55 Million USD | -374.123% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6170.309% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -493.443% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 863.462% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -80.355% |
| MediciNova, Inc. | -50.78 Million USD | -166.622% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -71.817% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -601811.536% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1998.383% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 32.239% |
| Biomea Fusion, Inc. | -166.57 Million USD | 18.713% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 24.347% |
| Mereo BioPharma Group plc | -51.46 Million USD | -163.071% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -42.761% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 53.908% |
| Absci Corporation | -72.59 Million USD | -86.507% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3065.396% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 42.245% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -43.72% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -41.49% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -246.531% |
| Allakos Inc. | -24.97 Million USD | -442.142% |
| Imunon, Inc. | -4.21 Million USD | -3113.212% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -818.464% |
| BioAtla, Inc. | -109.01 Million USD | -24.208% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18495.09% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -14319.595% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1231.539% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -538.589% |
| XOMA Corporation | -29 Million USD | -366.897% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -717.633% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1401.775% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1717.694% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -8.636% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 34.955% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -65.568% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -45.963% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -15659.139% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3421.456% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8443.141% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.805% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11296.011% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3183.58% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 219.315% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 188254.86% |
| Orgenesis Inc. | 21.78 Million USD | 721.557% |
| Entera Bio Ltd. | -10.62 Million USD | -1173.873% |
| GH Research PLC | -78.07 Million USD | -73.419% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -507.502% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -407.896% |
| Xencor, Inc. | 29.64 Million USD | 556.753% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6773.752% |
| Replimune Group, Inc. | 1.41 Million USD | 9689.235% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -55186.067% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -7.106% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11296.011% |
| Portage Biotech Inc. | -4.98 Million USD | -2618.33% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -601811.536% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -104.773% |
| OncoCyte Corporation | -6.56 Million USD | -1963.081% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 15187.814% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2872.138% |
| Purple Biotech Ltd. | -14.13 Million USD | -857.703% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -469.961% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1968.755% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -711.159% |
| HilleVax, Inc. | -165.48 Million USD | 18.18% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5234.909% |
| Tharimmune, Inc. | -10.93 Million USD | -1138.186% |
| Genprex, Inc. | -6.73 Million USD | -1909.609% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 63.287% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -53.064% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9564.525% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3982.068% |
| OKYO Pharma Limited | -826.84 Thousand USD | -16275.44% |
| Savara Inc. | 153 Thousand USD | 88596.732% |
| Curis, Inc. | -23.88 Million USD | -466.836% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2525.094% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -17348.184% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2081.057% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11526.16% |
| BeiGene, Ltd. | -2.25 Billion USD | 93.99% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1197.378% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 77.738% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 27.042% |
| Erasca, Inc. | -37.21 Million USD | -263.822% |
| bluebird bio, Inc. | 108.57 Million USD | 224.711% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10413.296% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 135.749% |
| DBV Technologies S.A. | -126.98 Million USD | -6.626% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10413.296% |
| Moderna, Inc. | -2.9 Billion USD | 95.342% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1207.96% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1145.859% |
| Molecular Templates, Inc. | 707 Thousand USD | 19251.344% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -331.609% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 139.064% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -64.997% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -47.607% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -319.559% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -293.879% |
| MacroGenics, Inc. | -66.98 Million USD | -102.135% |
| RenovoRx, Inc. | -1.17 Million USD | -11443.052% |
| Adicet Bio, Inc. | -138.78 Million USD | 2.44% |
| Prime Medicine, Inc. | -27.94 Million USD | -384.593% |
| Aditxt, Inc. | 18.12 Million USD | 847.204% |
| Adagene Inc. | -87.62 Million USD | -54.518% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3150.566% |
| Quantum-Si incorporated | -118.55 Million USD | -14.207% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 476.059% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1711.568% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -179.123% |
| SciSparc Ltd. | -2.06 Million USD | -6456.901% |
| Vericel Corporation | 1.27 Million USD | 10702.976% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1029.114% |
| Minerva Neurosciences, Inc. | 41 Million USD | 430.21% |
| Generation Bio Co. | 31.44 Million USD | 530.552% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 22.789% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -337.862% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 216.13% |
| Invivyd, Inc. | -198.47 Million USD | 31.78% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -49.994% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5547.106% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -91.27% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1883.883% |
| 2seventy bio, Inc. | 181.71 Million USD | 174.512% |
| ADMA Biologics, Inc. | 90.06 Million USD | 250.334% |
| Clene Inc. | 3.34 Million USD | 4153.892% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1390.746% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -529.445% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1998.383% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 60.654% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -420.776% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 176.21% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3209.246% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2806.917% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2499.347% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -3.911% |
| Evaxion Biotech A/S | 5.28 Million USD | 2661.074% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -20.283% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -3.144% |
| Trevena, Inc. | 2.25 Million USD | 6096.457% |
| Surrozen, Inc. | -32.66 Million USD | -314.524% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -162.862% |
| Cingulate Inc. | 3.08 Million USD | 4492.278% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4510.146% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1983.957% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1357.289% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -70.695% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -3.003% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -28.29% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3334.25% |
| Kronos Bio, Inc. | -36.05 Million USD | -275.548% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1539.048% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9385.885% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -149.558% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1039.208% |
| ImmunityBio, Inc. | 618.22 Million USD | 121.901% |
| Korro Bio, Inc. | -132.94 Million USD | -1.848% |
| Kineta, Inc. | -4.54 Million USD | -2881.722% |
| BioVie Inc. | -17.73 Million USD | -663.576% |
| Codexis, Inc. | -43.27 Million USD | -212.912% |
| Celularity Inc. | 65.19 Million USD | 307.701% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4172.641% |
| Celcuity Inc. | 6.78 Million USD | 2096.017% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3923.841% |
| Cibus, Inc. | -8.07 Million USD | -1576.157% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3101.703% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3062.801% |
| IN8bio, Inc. | -16.38 Million USD | -726.164% |
| Kodiak Sciences Inc. | -103.87 Million USD | -30.349% |
| Annexon, Inc. | -193.75 Million USD | 30.118% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 376211.111% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -673.759% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3754.256% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.843% |
| Eyenovia, Inc. | 1.25 Million USD | 10857.113% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 603.252% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4075.146% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -307.255% |
| Arcellx, Inc. | -296.95 Million USD | 54.404% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -594.145% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -129.979% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -553.254% |
| Moolec Science SA | 117.61 Thousand USD | 115220.392% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -252.613% |
| Geron Corporation | 14.76 Million USD | 1017.282% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -257.086% |
| Royalty Pharma plc | 5.65 Billion USD | 102.393% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 4.258% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1837.213% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2424.773% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 3.788% |
| Humacyte, Inc. | -22.48 Million USD | -502.152% |
| Structure Therapeutics Inc. | -124.33 Million USD | -8.896% |
| 89bio, Inc. | -289.05 Million USD | 53.157% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -436.408% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7493.943% |
| Genelux Corporation | -6.89 Million USD | -1862.603% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -335.944% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 261.964% |
| Notable Labs, Ltd. | -9.77 Million USD | -1285.025% |
| Liquidia Corporation | -80.17 Million USD | -68.878% |
| Mustang Bio, Inc. | -3.73 Million USD | -3524.197% |
| Immunovant, Inc. | -635.22 Million USD | 78.685% |
| Quantum-Si incorporated | -118.55 Million USD | -14.207% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -670.895% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3168.163% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1786.807% |
| Acasti Pharma Inc. | -23 Million USD | -488.568% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3921.111% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -733.263% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 1.699% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4244.81% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -509.032% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -629.172% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 20.013% |
| PepGen Inc. | -60.67 Million USD | -123.175% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -489.311% |
| United Therapeutics Corporation | -507.7 Million USD | 73.331% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -607.937% |
| Solid Biosciences Inc. | -47.75 Million USD | -183.56% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15606.035% |
| Immuneering Corporation | -54.94 Million USD | -146.438% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3121.134% |
| Silo Pharma, Inc. | -3.52 Million USD | -3741.889% |
| Belite Bio, Inc | -87.27 Million USD | -55.149% |
| XOMA Corporation | -29 Million USD | -366.897% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -91.522% |
| Bionomics Limited | 227 Million USD | 159.645% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -16.441% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5245.44% |
| uniQure N.V. | -102.95 Million USD | -31.519% |
| Cassava Sciences, Inc. | -121.13 Million USD | -11.775% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3150.566% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 430.639% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1032.012% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4275.929% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 127835.849% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4075.146% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1620.494% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1725.782% |
| Altimmune, Inc. | -134.48 Million USD | -0.679% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 168.361% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5245.44% |
| Compugen Ltd. | -12.9 Million USD | -949.287% |
| Peak Bio, Inc. | 10.34 Million USD | 1409.458% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -47744.523% |
| Benitec Biopharma Inc. | -50.58 Million USD | -167.684% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -29.771% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 789.234% |
| Zura Bio Limited | -99.8 Million USD | -35.663% |
| PolyPid Ltd. | 6.17 Million USD | 2294.489% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 282.677% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 789.234% |
| Instil Bio, Inc. | 75.35 Million USD | 279.676% |
| argenx SE | -2.02 Billion USD | 93.326% |
| Immunome, Inc. | -97.02 Million USD | -39.546% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -501.912% |
| Verona Pharma plc | -220.44 Million USD | 38.578% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -88.729% |
| Shattuck Labs, Inc. | -121.42 Million USD | -11.51% |
| CervoMed Inc. | -7.79 Million USD | -1637.491% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 27.008% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2996.273% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -2.778% |
| Moolec Science SA | 117.61 Thousand USD | 115220.392% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5817.892% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 951.659% |
| AnaptysBio, Inc. | -18.15 Million USD | -645.964% |
| Design Therapeutics, Inc. | -18.15 Million USD | -646.006% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -92.381% |
| NeurAxis, Inc. | 145.7 Thousand USD | 93030.679% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1305.484% |
| Lumos Pharma, Inc. | -28.49 Million USD | -375.204% |
| Achilles Therapeutics plc | -126.92 Million USD | -6.678% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -88.729% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -20548.743% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -551.782% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9385.885% |
| Nutriband Inc. | -251.65 Thousand USD | -53703.391% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -928.016% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1719.892% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 139.8% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 670.466% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 69.741% |
| Palisade Bio, Inc. | -12.06 Million USD | -1022.441% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 3.5% |
| Beam Therapeutics Inc. | -262.72 Million USD | 48.463% |
| Neurogene Inc. | -131.95 Million USD | -2.611% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 720.645% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2674.59% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 64.103% |
| Sesen Bio, Inc. | -112.55 Million USD | -20.299% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -35.59% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5667.118% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -246.948% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -62.58% |
| Athira Pharma, Inc. | -88.99 Million USD | -52.137% |
| Vaccinex, Inc. | -1.28 Million USD | -10412.422% |
| HCW Biologics Inc. | 2.85 Million USD | 4839.774% |
| XOMA Corporation | -29 Million USD | -366.897% |
| Nektar Therapeutics | 210.24 Million USD | 164.403% |
| Arvinas, Inc. | -313.8 Million USD | 56.851% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8443.141% |
| Merus N.V. | -192.88 Million USD | 29.802% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 325.723% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1851.571% |
| Rezolute, Inc. | -68.16 Million USD | -98.627% |
| Clene Inc. | 3.34 Million USD | 4153.892% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -926.769% |
| BeyondSpring Inc. | -13.75 Million USD | -884.369% |
| Synlogic, Inc. | -6.68 Million USD | -1925.43% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 12040.035% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1501.419% |
| Peak Bio, Inc. | 10.34 Million USD | 1409.458% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -64.281% |
| Krystal Biotech, Inc. | -350.23 Million USD | 61.34% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 209.084% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 19.88% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4188.686% |
| MannKind Corporation | 143.89 Million USD | 194.094% |
| Ikena Oncology, Inc. | -109.15 Million USD | -24.043% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1688.403% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -309.063% |
| Gossamer Bio, Inc. | 180.35 Million USD | 175.074% |
| CohBar, Inc. | -5.93 Million USD | -2183.024% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -355.157% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3065.396% |
| Legend Biotech Corporation | -949.39 Million USD | 85.738% |
| Mural Oncology plc | -255.84 Million USD | 47.077% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 520.301% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2774.343% |
| Disc Medicine, Inc. | -358.28 Million USD | 62.208% |
| Champions Oncology, Inc. | 4.81 Million USD | 2913.799% |
| REGENXBIO Inc. | 54.76 Million USD | 347.225% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -50251.98% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 10.345% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1402.44% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -67.817% |
| Vaxart, Inc. | -8.24 Million USD | -1543.004% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -169.829% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -6.475% |
| Cellectis S.A. | -43.85 Million USD | -208.745% |
| Longeveron Inc. | -2.9 Million USD | -4556.121% |
| Repare Therapeutics Inc. | -107.85 Million USD | -25.535% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.982% |
| Inozyme Pharma, Inc. | 12 Million USD | 1227.957% |
| Revolution Medicines, Inc. | -608.2 Million USD | 77.738% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10908.13% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 48.928% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 9.777% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -765.342% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -18197.297% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.584% |
| Denali Therapeutics Inc. | -74.86 Million USD | -80.859% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1029.114% |
| Veru Inc. | 4.77 Million USD | 2932.654% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1103.984% |
| Cingulate Inc. | 3.08 Million USD | 4492.278% |
| Passage Bio, Inc. | 4.58 Million USD | 3053.108% |
| Context Therapeutics Inc. | -14.44 Million USD | -837.035% |
| Exicure, Inc. | 5.84 Million USD | 2414.926% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 41.227% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -242.178% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 962.915% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -130.19% |
| Nuvalent, Inc. | -335.38 Million USD | 59.629% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7907.0% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -81.789% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1423.06% |
| OmniAb, Inc. | 9.2 Million USD | 1571.259% |
| Anew Medical, Inc. | 1.43 Million USD | 9552.238% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 926.529% |
| Lipocine Inc. | -4.75 Million USD | -2747.773% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -23.284% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 988.976% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -167.277% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 643.95% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1914.581% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -105.691% |
| Ocugen, Inc. | -32.52 Million USD | -316.346% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -58.224% |
| Q32 Bio Inc. | -37.94 Million USD | -256.804% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -21460.51% |
| Alumis Inc. Common Stock | -13.52 Million USD | -900.813% |
| Equillium, Inc. | -22.39 Million USD | -504.68% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -429.568% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -314.997% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -54515.493% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 201.013% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4333.896% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 41325.06% |
| Dominari Holdings Inc. | 195 Thousand USD | 69535.897% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2470.767% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1418.448% |
| Bio-Techne Corporation | 267.74 Million USD | 150.57% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -735.338% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -14.654% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1511.329% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -970.271% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 44.762% |
| Nkarta, Inc. | 57.29 Million USD | 336.304% |
| BioCardia, Inc. | 212 Thousand USD | 63967.925% |
| Iterum Therapeutics plc | 13.43 Million USD | 1107.59% |